Ming Qiao

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 5

Top Topics

Systematic Review

Signaling Pathway

Liquid Chromatography Tandem Mass Spectrometry

Top Venues

Evidence-based complementary and alternative medicine : eCAM

This page only lists publications with an associated author ORCID identifier.

Publications

Xiaoyi Meng, Min Li, Ming Qiao, Xue Li, Jianhua Yang, Junping Hu
Hugan Buzure Induces Autophagy and Apoptosis in Hepatocellular Carcinoma by Inhibiting PI3K/Akt/mTOR Signaling Pathway. Evidence-based complementary and alternative medicine : eCAM 2022 (2022)
Yi Zhu, Jian-Hua Yang, Jun-Ping Hu, Ming Qiao
Association of glutathione S-transferases (GSTT1, GSTM1 and GSTP1) genes polymorphisms with nonalcoholic fatty liver disease susceptibility: A PRISMA-compliant systematic review and meta-analysis. Medicine 101 (38) (2022)
Ming Qiao, Jian-Hua Yang, Yi Zhu, Jun-Ping Hu
Association of sorting and assembly machinery component 50 homolog gene polymorphisms with nonalcoholic fatty liver disease susceptibility. Medicine 101 (29) (2022)
Ming Qiao, Jianhua Yang, Yao Zhao, Yi Zhu, Xiaomei Wang, Xinling Wang, Jun-Ping Hu
Corrigendum to "Antiliver Fibrosis Screening of Active Ingredients from Apium graveolens L. Seeds via GC-TOF-MS and UHPLC-MS/MS". Evidence-based complementary and alternative medicine : eCAM 2022 (2022)
Ming Qiao, Jianhua Yang, Yao Zhao, Yi Zhu, Xiaomei Wang, Xinling Wang, Jun-Ping Hu
Antiliver Fibrosis Screening of Active Ingredients from Apium graveolens L. Seeds via GC-TOF-MS and UHPLC-MS/MS. Evidence-based complementary and alternative medicine : eCAM 2020 (2020)